Cargando…
Current peptide vaccine and immunotherapy approaches against Alzheimer's disease
Peptide vaccines and immunotherapies against aggregating proteins involved in the pathogenesis and progression of Alzheimer's disease (AD)—the β‐amyloid peptide (Aβ) and tau—are promising therapeutic avenues against AD. Two decades of effort has led to the controversial United States Food and D...
Autores principales: | Parrocha, Chelsea Marie T., Nowick, James S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916509/ https://www.ncbi.nlm.nih.gov/pubmed/36778914 http://dx.doi.org/10.1002/pep2.24289 |
Ejemplares similares
-
A cyclic peptide inhibitor of the SARS-CoV-2 main protease
por: Kreutzer, Adam G., et al.
Publicado: (2021) -
Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: A tutorial for students and scientists
por: Zhang, Sheng, et al.
Publicado: (2021) -
Structure-Based Drug Design of an Inhibitor of the SARS-CoV-2 (COVID-19) Main Protease Using Free Software: A Tutorial for Students and Scientists
por: Zhang, Sheng, et al.
Publicado: (2020) -
Immunotherapy and vaccination against infectious diseases
por: Ebbers, Meinolf, et al.
Publicado: (2020) -
Active immunotherapy options for Alzheimer’s disease
por: Winblad, Bengt, et al.
Publicado: (2014)